|
KarXT + KarX-EC Arm Matching Placebo Clinical Trials
1 actively recruiting trial across 1 location
No change since July 2026
Pipeline
Phase 3: 1
Top Sponsors
- Bristol-Myers Squibb1
Indications
- Alzheimer's Disease1
- Psychosis1
- Alzheimer Disease1
Gilbert, Arizona1 trial
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Gilbert Neurology Partners/CCT Research
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.